Pierre-Marie Roger

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

The Journal of antimicrobial chemotherapy

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre-Marie Roger, Frédéric Assi, Eric Denes
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Pierre-Marie Roger, Frédéric Assi, Eric Denes
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Pierre-Marie Roger, Frédéric Assi, Eric Denes
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate. The Journal of antimicrobial chemotherapy (2023)
Livia Claude, Frédéric Martino, Patricia Hermand, Bassel Chahim, Pierre-Marie Roger, Marie de Bourayne, Yohann Garnier, Benoit Tressières, Yves Colin, Caroline Le Van Kim, Marc Romana, Véronique Baccini
Platelet caspase-1 and Bruton tyrosine kinase activation in patients with COVID-19 is associated with disease severity and reversed in vitro by ibrutinib. Research and practice in thrombosis and haemostasis 6 (8) (2022)
Livia Claude, Frédéric Martino, Patricia Hermand, Bassel Chahim, Pierre-Marie Roger, Marie de Bourayne, Yohann Garnier, Benoit Tressières, Yves Colin, Caroline Le Van Kim, Marc Romana, Véronique Baccini
Platelet caspase-1 and Bruton tyrosine kinase activation in patients with COVID-19 is associated with disease severity and reversed in vitro by ibrutinib. Research and practice in thrombosis and haemostasis 6 (8) (2022)